Market Overview:
The global positron emission tomography (PET) system market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer and other diseases, growing demand for early diagnosis and treatment, and technological advancements in PET systems. The direct imaging segment is expected to account for the largest share of the global PET system market in 2018. This segment is also projected to grow at a higher CAGR than indirect imaging and alternative imaging segments during the forecast period. The large share of this segment can be attributed to its advantages such as high spatial resolution, ability to image small lesions, and low radiation dose exposure. Oncology is estimated to be the largest application area for PET systems in 2018.
Product Definition:
A positron emission tomography (PET) system is a medical device that uses radiation to produce images of the inside of the body. PET systems are used to diagnose and treat a variety of diseases, including cancer.
Direct Imaging:
The direct imaging is the process of observing a particular body part using optical or electromagnetic radiation without any intermediate conversion to energy. The term usually refers to X-ray, Computed Tomography (CT), ultrasound and Magnetic Resonance Imaging (MRI). In PET, there is no need for absorbing or exciting the radiations; instead, the information is directly obtained from molecules that are present in a specific concentration.
PET has several advantages over other diagnostic techniques such as CT.
Indirect Imaging:
The images that are obtained from this interaction is called as Indirect Imaging Tomography (PET) image.
The advantages of indirect imaging over direct imaging include; it's non-invasive, there's no risk involved in taking the radiotracers,.
Application Insights:
The tumor diagnosis segment dominated the global market in 2017 owing to the rising prevalence of cancer and increasing government initiatives for early detection. Moreover, growing demand for sensitive and accurate PET imaging devices for oncology applications is expected to drive growth during the forecast period.
Coronary heart disease diagnosis held a significant share in 2017 due to factors such as an increase in patient awareness about early detection of coronary heart disease along with technological advancements that have improved accuracy of PET scanners. For instance, introduction of new generation PET scanners with enhanced resolution has led to better accuracy while diagnosing CHD.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies and increasing prevalence of cancer and brain disorders. Moreover, rising preference for minimally invasive surgeries is also expected to drive regional growth over the forecast period.
The Asia Pacific held a significant share in 2018 as several multinational companies are focusing on expanding their business in this region. For instance, Siemens opened its new Healthcare Accelerator Centre (HAC) in Singapore with an aim towards developing novel solutions for better health outcomes through research and innovation. Such initiatives are anticipated to boost demand for PET systems over the coming years.
Growth Factors:
- Increasing demand for PET scans for cancer detection and treatment planning
- Rising prevalence of cancer and other chronic diseases
- Growing number of PET imaging centers worldwide
- Technological advancements in PET scanners and software platforms
- Increasing use of molecular imaging in drug development
Scope Of The Report
Report Attributes
Report Details
Report Title
Positron Emission Tomography (PET) System Market Research Report
By Type
Direct Imaging, Indirect Imaging, Alternative Imaging
By Application
Tumor Diagnosis, Coronary Heart Disease (CHD) Diagnosis, Brain Disease Diagnosis
By Companies
Boston Scientific, SynchroPET, Zecotek Photonics, Brain Biosciences, GE Healthcare, Philips Healthcare, Ray Vision Intl
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Positron Emission Tomography (PET) System Market Report Segments:
The global Positron Emission Tomography (PET) System market is segmented on the basis of:
Types
Direct Imaging, Indirect Imaging, Alternative Imaging
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tumor Diagnosis, Coronary Heart Disease (CHD) Diagnosis, Brain Disease Diagnosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- SynchroPET
- Zecotek Photonics
- Brain Biosciences
- GE Healthcare
- Philips Healthcare
- Ray Vision Intl
Highlights of The Positron Emission Tomography (PET) System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Direct Imaging
- Indirect Imaging
- Alternative Imaging
- By Application:
- Tumor Diagnosis
- Coronary Heart Disease (CHD) Diagnosis
- Brain Disease Diagnosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Positron Emission Tomography (PET) System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
PET is a radiology technology that uses positron emission tomography (PET) to produce images of the body. PET scans use a small amount of radioactive material to create pictures of the body's organs and tissues.
Some of the major companies in the positron emission tomography (pet) system market are Boston Scientific, SynchroPET, Zecotek Photonics, Brain Biosciences, GE Healthcare, Philips Healthcare, Ray Vision Intl.
The positron emission tomography (pet) system market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Positron Emission Tomography (PET) System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Positron Emission Tomography (PET) System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Positron Emission Tomography (PET) System Market - Supply Chain
4.5. Global Positron Emission Tomography (PET) System Market Forecast
4.5.1. Positron Emission Tomography (PET) System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Positron Emission Tomography (PET) System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Positron Emission Tomography (PET) System Market Absolute $ Opportunity
5. Global Positron Emission Tomography (PET) System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Positron Emission Tomography (PET) System Market Size and Volume Forecast by Type
5.3.1. Direct Imaging
5.3.2. Indirect Imaging
5.3.3. Alternative Imaging
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Positron Emission Tomography (PET) System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Positron Emission Tomography (PET) System Market Size and Volume Forecast by Application
6.3.1. Tumor Diagnosis
6.3.2. Coronary Heart Disease (CHD) Diagnosis
6.3.3. Brain Disease Diagnosis
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Positron Emission Tomography (PET) System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Positron Emission Tomography (PET) System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Positron Emission Tomography (PET) System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Positron Emission Tomography (PET) System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Positron Emission Tomography (PET) System Demand Share Forecast, 2019-2026
9. North America Positron Emission Tomography (PET) System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Positron Emission Tomography (PET) System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Positron Emission Tomography (PET) System Market Size and Volume Forecast by Application
9.4.1. Tumor Diagnosis
9.4.2. Coronary Heart Disease (CHD) Diagnosis
9.4.3. Brain Disease Diagnosis
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Positron Emission Tomography (PET) System Market Size and Volume Forecast by Type
9.7.1. Direct Imaging
9.7.2. Indirect Imaging
9.7.3. Alternative Imaging
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Positron Emission Tomography (PET) System Demand Share Forecast, 2019-2026
10. Latin America Positron Emission Tomography (PET) System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Positron Emission Tomography (PET) System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Positron Emission Tomography (PET) System Market Size and Volume Forecast by Application
10.4.1. Tumor Diagnosis
10.4.2. Coronary Heart Disease (CHD) Diagnosis
10.4.3. Brain Disease Diagnosis
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Positron Emission Tomography (PET) System Market Size and Volume Forecast by Type
10.7.1. Direct Imaging
10.7.2. Indirect Imaging
10.7.3. Alternative Imaging
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Positron Emission Tomography (PET) System Demand Share Forecast, 2019-2026
11. Europe Positron Emission Tomography (PET) System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Positron Emission Tomography (PET) System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Positron Emission Tomography (PET) System Market Size and Volume Forecast by Application
11.4.1. Tumor Diagnosis
11.4.2. Coronary Heart Disease (CHD) Diagnosis
11.4.3. Brain Disease Diagnosis
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Positron Emission Tomography (PET) SystemMarket Size and Volume Forecast by Type
11.7.1. Direct Imaging
11.7.2. Indirect Imaging
11.7.3. Alternative Imaging
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Positron Emission Tomography (PET) System Demand Share, 2019-2026
12. Asia Pacific Positron Emission Tomography (PET) System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Positron Emission Tomography (PET) System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Positron Emission Tomography (PET) System Market Size and Volume Forecast by Application
12.4.1. Tumor Diagnosis
12.4.2. Coronary Heart Disease (CHD) Diagnosis
12.4.3. Brain Disease Diagnosis
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Positron Emission Tomography (PET) System Market Size and Volume Forecast by Type
12.7.1. Direct Imaging
12.7.2. Indirect Imaging
12.7.3. Alternative Imaging
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Positron Emission Tomography (PET) System Demand Share, 2019-2026
13. Middle East & Africa Positron Emission Tomography (PET) System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Positron Emission Tomography (PET) System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Positron Emission Tomography (PET) System Market Size and Volume Forecast by Application
13.4.1. Tumor Diagnosis
13.4.2. Coronary Heart Disease (CHD) Diagnosis
13.4.3. Brain Disease Diagnosis
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Positron Emission Tomography (PET) System Market Size and Volume Forecast by Type
13.7.1. Direct Imaging
13.7.2. Indirect Imaging
13.7.3. Alternative Imaging
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Positron Emission Tomography (PET) System Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Positron Emission Tomography (PET) System Market: Market Share Analysis
14.2. Positron Emission Tomography (PET) System Distributors and Customers
14.3. Positron Emission Tomography (PET) System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boston Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. SynchroPET
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Zecotek Photonics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Brain Biosciences
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GE Healthcare
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Philips Healthcare
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ray Vision Intl
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook